Meanwhile, Cutler reassured GLP-1 users that pancreatitis is a recognized, but uncommon risk associated with the injections
The study assessed data from 16,827 patients reviewed by neuro-ophthalmologists, focusing on individuals with type 2 diabetes or those overweight or obese
When demand for GLP-1s and GIP/GLP-1s leaped past what the manufacturers could provide, compounded versions popped up in online pharmacies and brick-and-mortar stores, for the following drugs: Ozempic (semaglutide) Rybelsus (semaglutide) Wegovy (semaglutide) Zepbound (tirzepatide) Mounjaro (tirzepatide) Retatrutide (This drug is not FDA approved.) However, the FDA cautions that compounded drugs, while useful or even necessary in some situations, are not FDA-reviewed or approved, so the FDA cannot guarantee their safety, quality, or effectiveness
Slows Gastric Emptying Food stays in your stomach longer, which prolongs satiety and curbs snacking or overeating
Targeting both aspects of the disease at once remains a significant challenge